P2P Foundation

Researching, documenting and promoting peer to peer practices


Featured Book

Cloud Time


Open Calls


Mailing List

Subscribe

Translate

  • Recent Comments:

    • David de Ugarte: Probably the most terrible fallacies of our times are: 1. «abundance equals ever increasing consumption» (neoliberal falacy) 2....

    • karirin: ABundance should exists but it must be applied in real world http://fr.ekopedia.org/Hydropo nie When there will be free food, in our world...

    • Tom Crowl: This is great stuff! It might be assumed that I “LOVE” money in politics… (since I’m advocating more people...

    • Tom Crowl: Let me confront an obvious question (to me anyway)… since I’m zealously advocating the political micro-contribution as...

    • Jaap: You are spot on. Hierarchies are outdated and do not work any more. The Dilbert (model for modern knowledge worker) and his boss show that...

Open Notebook Science: Interview with Jean-Claude Bradley

photo of Michel Bauwens

Michel Bauwens
17th October 2010


Via Richard Poynder:

Jean-Claude Bradley is an organic chemist at Drexel University in Philadelphia. As with most scientists, Bradley used to be very secretive. He kept his research under wraps until publication and frequently applied for patents on his work in nanotechnology and gene therapy.

However, he asked himself a difficult question 5 years ago: Was his research having the kind of impact he would like? He had to conclude that the answer was “no”, and this was partly a consequence of the culture of secrecy that permeates research today.

So Bradley determined to be more open. Since his collaborators were not of the same mind, he severed his ties with them and, in 2005, he launched a web-based initiative called UsefulChem.

As the name implies, the aim of the initiative was also to work in the world of useful science and, today, Bradley makes new anti-malarial compounds. This is potentially very useful: Malaria kills millions of people each year and, since most of those people live in the developing world, large pharmaceutical companies are disinclined to devote much time to developing new treatments.

And in the interests of openness, Bradley makes the details of every experiment done in his lab freely available on the web. He doesn’t limit this to just a description, but he includes all the data generated from these experiments too, even the failed experiments.

He named his new technique Open Notebook Science (ONS). The questions we asked were:

What exactly is ONS?

How does it differ from Open Access?

What does ONS mean for researchers?

What does ONS mean for publishers?

What does ONS mean for librarians?

What role do institutional repositories have to play in ONS?

Jean Claude-Bradley answers all these questions and more in an interview published in the September issue of Information Today. The interview is freely available here.

Share

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>